Abstract-It has always been desirable for clinicians to ascertain whether glomerular filtration rate has recovered or still depressed at the bedside as increase in serum creatinine often indicates acute kidney injury to a clinician. In recent years, several clinical studies have developed mathematical models to simulate the creatinine response to changes in glomerular filtration rate which includes the estimated glomerular filtration rate Chronic Kidney Disease Epidemiology Collaboration, the Chen-kinetic estimated GFR model and the modified Chen-Pianta-EndrePickering-Bukley-Pecke kinetic estimated GFR model. Another study also showed that the ratio of creatinine excretion rates to creatinine production rates may predict changes in plasma concentration. The aim of this study is to allow clinicians to gauge the performance of glomerular filtration rate estimation using the aforementioned equations and models to predict worsening of renal function, indicated by a low kinetic estimated glomerular filtration rate or creatinine production rates less than unity, or recovery of kidney function, indicated by high kinetic estimated glomerular filtration rate. In order to achieve this a mobile software is developed to aid data collection and calculation for the clinical study based on the aforementioned models. This paper summarises the implementation details of the native application development and presents the graphical user interface of the system in practice.
I. INTRODUCTION
Glomerular filtration rate (GFR) estimation is important in assessing kidney function as it is an indication of either renal recovery or acute kidney injury (AKI) and often gauged by measuring the changes in serum creatinine [1] , [2] . It has always been desirable for clinicians to ascertain whether GFR has recovered or still depressed at the bedside (i.e. at the time of measurement). However, in practice, GFR cannot be measured easily and instead estimated from equations using age, race, sex and serum creatinine [3] .
Among the models that may estimate GFR are the GFR Chronic Kidney Disease Epidemiology Collaboration (eGFR CKD-EPI) [3] - [5] and the kinetic estimated GFR (keGFR) [2] , [6] . The eGFR (CKD-EPI) has been widely used for estimating kidney function when the plasma creatinine is stable. However, studies have shown that when plasma creatinine changes rapidly, the eGFR model no longer provides a good estimation [2] . This is the condition in which the kinetic eGFR (keGFR) model supersedes the eGFR model whereby it enhances the fundamental clearance equation by allowing for the analysis of kidney function in acute settings.
Since estimation of GFR is important, it is no coincidence that there are several GFR mobile applications currently available; one GFR application on the iOS platform, by the name of eGFR Calculators by National Kidney Foundation and two on the android platform, by the name of eGFR Calculators and eGFR Calculator by National Kidney Foundation and Oguz Gelal. These mobile applications purely calculate the estimated GFR output and does not store any data. Hence, the user is neither able to retrieve previous calculations of estimated GFR values nor save patient readings necessary to obtain the eGFR output.
The application developed in this study enables storage of patient data such as patient information and consecutive creatinine readings which provides a systematic and accurate data collection method paramount for more accurate estimation of GFR from the models. This is an important step since the current system in Malaysian hospitals rely heavily on manual hard copy input of patient data [8] . The difficulty is compounded by the fact that the data set for the patient readings are large, complex and time dependent. Human error in transferring the data from the patient report as digital inputs to the equations may affect the accuracy of the model. Furthermore, the application that has been developed here allows for storage of all the calculated eGFR values computed based on several eGFR equations. This allows for more efficient monitoring of GFR, enables comparison between different GFR models in the Malaysian cohort and leave open the possibility to develop a more accurate eGFR model more suitable for local patients. This is indeed important since eGFR models are developed based on patient data from the United States whereas studies have shown that ethnicity, diet and demographics to be factors affecting serum creatinine concentration [7] .
In this application, three mathematical models aimed to facilitate estimation of GFR are implemented. The first model is the eGFR model developed by [3] . The second model was developed by [2] based on first principles in physiology of creatinine balance which will be called the Chen-keGFR in this paper. The third model is the CPEPBP-keGFR model [6] which is a modification of the Chen-keGFR. In addition to these mathematical models, the ratio of creatinine excretion rates (E) to creatinine production rates (E/G Ratio) developed by [1] will also be incorporated in the application as it has been shown successful in predicting changes in plasma concentration. Further details of each models are explained in the next section. The outcome of the native application is to facilitate data collection and provide clinicians with the ability to predict recovery or worsening of renal function at the bedside. It is endeavoured that the application will create a supportive ecosystem for the development of clinical research, specifically to improve the accuracy of the available GFR estimation models in the local context.
II. MODELLING OF THE GLOMERULAR FILTRATION RATE A. eGFR model
The eGFR model derived by [3] was shown to improve accuracy of the previously used Modification of Diet in Renal Disease (MDRD) equation across a wide range of clinical conditions and variety of population. The model is given in Table I .
TABLE I THE CKP-EPI EQUATION FOR ESTIMATING GFR [3]
Gender Serum Creatinine Equation
B. The Chen-keGFR model
The Chen-keGFR model derived by [2] based on the creatinine production rate, initial creatinine content and the volume of distribution. The quantitative difference between consecutive plasma creatinine over a period of time is also required which allows quantifying of creatinine excretion and hence converted to creatinine clearance rate. The advantage of using this model of the eGFR model is its ability to estimate the kidney function when the variation of plasma creatinine is acute. the Chen-keGFR model is given as follows,
where keGFR Chen is the Chen-keGFR equation with units ml/min, SSP Cr is the steady-state plasma creatinine in mg/dl, CrCl is the corresponding creatinine clearance in ml/min, Mean(P Cr ) is the mean plasma creatinine per day in mg/dl, P Cr is the change in plasma creatinine in mg/dl, t(hours) is the interval in hours between two consecutive creatinines in hours, Max( P Cr /Day) is the maximal change in the plasma creatinine that occurs in a day.
Since Max( P Cr /Day) must be greater than any P Cr indexed to a day, thus the ratio, 24 × P Cr t(hours) × Max( P Cr /Day) will never exceed 1. Thus, the lowest possible value for the expression 1 − 24 × P Cr t(hours) × Max( P Cr /Day) will be zero. Since Max( P Cr /Day) has effectively set the lower bound, negative keGFR Chen is then avoided.
C. The CPEPBP-keGFR model
In order to improve early prediction of delayed graft function (DFG) to facilitate patient management after kidney transplantation, [6] modified the Chen-keGFR model which is also based on plasma cystatin C (pCysC). This is an advantage since studies have shown that plasma cystatin C outperforms serum creatinine for DGF prediction [9] , [10] . Results from this study demonstrated that the formula is accurate in predicting 4 hours of renal transplantation. The CPEPBP-keGFR model derived by [6] is given as follows,
where B C × eGFR is the circulating biomarker concentration (Serum creatinine or plasma cystatin C), eGFR is the unadjusted eGFR in Table I , Mean(B C ) is the mean of two consecutive values of B C , P Cr is the change in biomarker concentration, t(hours) is the interval in hours between two consecutive biomarkers in hours, Max( B C /Day) is the maximal increase in the biomarker concentration that occurs in a day when GFR is zero. Note that the units are similar to those in the Chen-keGFR model. Since daily circulating biomarker production can also be expressed as
Thus the maximum increase in the biomarker can be expressed as
where V d = 0.6×w [2] for serum creatinine and V d = 0.2×w [11] for plasma cystatin C. The variable w refers to body
Since eGFR must be a positive value, the calculated CPEPBPkeGFR will be assigned 0 if it results in a negative value [6] .
D. E/G ratio A study by [1] showed that the change in plasma creatinine concentration may be predicted by the following ratio:
The ratio E/G > 1 indicates an excess of creatinine excretion due to a recovery of GFR following an earlier loss and E/G < 1 is an evidence of a prior loss of GFR without subsequent recovery. A steady state has been reached when E/G = 1. The creatinine excretion rate (E) is given by E = Urine concentration × Average urine Flow Rate (6) The average urine flow rate in Equation 6 is taken during the first 4 hours. Following [12] , the creatinine production (G) may be estimated by the equations given in Table II . 
III. RESULTS AND DISCUSSION

A. Application Overview
The outcome of this study is the eGFR Tracker application which is aimed to provide medical experts with a user interface for easy input of patient data and retrieval of GFR measurements. A comparison between the GFR models will be implemented to allow for improved GFR modelling. In the initial stage, the data obtained from the mobile application will be stored on the device memory. It is endeavoured that the data may reside at a distributed Cloud Storage facility with proper user authentication and data encryption in future work.
The selected software stack is iOS. The following are the reason for this selection: 1) Less resources for development since there are limited number of iOS devices 2) Built on secure and robust kernal 3) Vendor support and large and vibrant community which reduces development time and efforts 4) Currently available physical resources are iOS devices 
B. Data Management and Data Processing
The data management functions as a medical data storage and query which will be stored on disk. There are several data persistence options which include default system, property lists, SQLite and core data. The application will implement core data which has an advantage of working with data as objects. Furthermore, XCode provides a graphical interface for core data which is built in the model editor and is capable in handling any types of data.
Core data is a framework that provides relational object oriented model which may be serialised in XML, binary or SQLite. The core data stack is the heart of core data which consist of key objects; the managed object model, the persistent coordinator and the managed object contexts (see Figure 1 ). The Core Data Model is responsible in organising data elements, defines structure of objects and standardises how the elements relate to each other. The persistent core data is the backing store where the actual data is stored. Access to data in the persistent store is implemented via the persistent store coordinator. In the context of the application being developed, the patient forms the patient entity while the attributes consist of patient details, reading entries and calculated GFR data. The Managed Objects represent instances of data that defines the data structure such as entities and relationships whereas the managed Object Context describes the way core data is represented in the Persistent Store. These concepts are used rigorously in developing the app in order to exploit the built in storage capacities in the iOS environment.
Calculations of eGFR in Table I , Chen-keGFR in Equation  1 and CPEPBP-keGFR in Equation 5 will be implemented each time the user enters a reading for the patient (which are implemented in view controllers in Figures 2b and 2c. The resultant values will be stored in core data which may be queried upon request.
C. Application Implementation
The application may be summarised as follows: create new patient, add creatinine readings, displays patient history and
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GFR results for each patient.
Patient List: The patient list (see Figure 2a) will be set as the initial view controller that implements dynamic prototype table cells which will be populated by a list of patients that have been previously input. The button located in the navigation bar is to add a new patient. The disclosure indicator will direct the user to all information related to the patient.
New Patient and Add New Reading: In order to ensure the user inputs correct format for gender and ethnicity, the segmentation control, an object in UISegmented Control is exploited (see Figure 2b) . GFR measurements rely on consecutive readings of biomarkers B c and the date/time of the reading (see Figure 2b and 2c) . In order to ensure correct input for the date and time, the UIDate Picker Class will be implemented which provides the user with multiple rotating wheels which send an action message . The associated control event is UIControlEventValueChanged after the user finishes the rotation of the wheel.
Patient Information: The patient information (see Figure 2d ) will include informations such as personal detail, biomarker reading history (see Figure 2e) , and summarises results from the model (see Section A and Section B in Figure 2d .
Data Visualisation: Line graphs and several other visualisation tools were considered prior to the development. However, a simple table of date/time and data (see Figure 2d) was requested by the physician and hence was implemented in the final application.
In order to ensure patient security, editing of patient details are disabled. However, deletion of patients and reading entries will be allowed and integrated into the application in order to allow margin for human error in input. Furthermore, iOS built in UIAlertController was integrated to ensure that the user performs all relevant tasks.
Preliminary testing has been done with available patient records and mock patient data provided by the medical practitioners from Hospital Tuanku Ampuan Afzan (HTAA), Kuantan and International Islamic University of Malaysia Hospital (HUIAM), Kuantan. The testing involved calculation of the equations used in Section II based on the aforementioned data to ensure validity of the application. Furthermore, testing was done and validated with results in published literature to ensure accuracy of the equations coded into the application. In addition, the user interface was also rigorously tested by the developers and the medical practitioners to ensure ease of use, check usability conditions and verify data integrity, all navigations, date field and numeric formats. The user-interface of the application was improved based on the feedback obtained from the testing. The application will be utilised in HUIAM once the hospital is in full operation early next year.
IV. CONCLUSION AND FUTURE WORK
The outcome of this study, the eGFR Tracker application, will be deployed in a local hospital for a more systematic and accurate data collection to gauge the the feasibility of different GFR models and to gain understanding and insight in developing a more accurate and expedited estimation of kidney failure for local patients. Future work includes utilisation of cloud computing with Microsoft Azure. The usage of cloud computing provides cost-effective alternative to process and store vast amount of data for which are important factors for the implementation in public hospitals, provides convenient, on-demand network access that can be rapidly provisioned with minimal management effort. Furthermore, the use of multiple redundant sites improves reliability of cloud computing which makes it suitable for business continuity and disaster recovery. Microsoft Azure has been chosen for cloud computing integration since it also provides high security resources to protect data which is an important factor in dealing with medical data and powerful tools to visualise and process data such as machine learning. 
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